LCN2 deficiency ameliorates doxorubicin-induced cardiomyopathy in mice
Authors:
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 588, 8-14
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (2015R1A5A2008833)
This publication has 23 references indexed in Scilit:
- Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cellsMolecular and Cellular Endocrinology, 2016
- Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome AcidificationCirculation, 2016
- Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in miceFree Radical Biology and Medicine, 2015
- Oxidative stress and autophagy: the clash between damage and metabolic needsCell Death & Differentiation, 2014
- Prognostic Value of Plasma Neutrophil Gelatinase–Associated Lipocalin for Mortality in Patients With Heart FailureCirculation: Heart Failure, 2014
- The machinery of macroautophagyCell Research, 2013
- Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failureInternational Journal of Cardiology, 2013
- Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse modelToxicology and Applied Pharmacology, 2013
- Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytesCell and tissue research, 2012
- Why is autophagy important in human diseases?Experimental & Molecular Medicine, 2012